Search

Benjamin P Vokits

from New York, NY
Age ~49
Get Report
Also known as:
Ben Vokits
Phone and address:
301 W 45Th St APT 8K, New York, NY 10036
Related to:
Joshua G Cohen, 37Jeffrey D Cohen, 71Zachary CarnevaleWilliam CohenRon Vokits, 78Mark Carnevale
Connected to:
Lynda G Vokonas, 76Corwyn R Vokoun, 71Galina Vol, 44Meleseini S Vola, 42Velema L Vola, 69Jason A Volak, 45Martha A Volak, 49Edith M Voland, 89Hayley B Voland, 33Ken L Voland, 46

Benjamin Vokits Phones & Addresses

  • 301 W 45Th St APT 8K, New York, NY 10036
  • 5111 Pleasant Run Parkway South Dr S, Indianapolis, IN 46219 (317) 356-3949
  • Marion, IN
  • Lawrence Township, NJ

Work

Company: Bristol-myers squibb Feb 2008 Position: Research scientist ii

Education

Degree: Master of Science, Masters School / High School: Purdue University 2000 to 2006 Specialities: Organic Chemistry

Skills

Tuba • Drug Discovery • Medicinal Chemistry • Hplc • Lc Ms • Drug Development • Organic Chemistry • Chromatography • Technology Transfer • Glp • Clinical Development • Pharmaceutical Industry • Analytical Chemistry • Biotechnology • Cro

Industries

Pharmaceuticals

Resumes

Resumes

Benjamin Vokits Photo 1

Research Scientist Ii

View page
Location:
New York, NY
Industry:
Pharmaceuticals
Work:
Bristol-Myers Squibb
Research Scientist Ii
Eli Lilly and Company Jul 1999 - Jan 2008
Organic Chemist
Education:
Purdue University 2000 - 2006
Master of Science, Masters, Organic Chemistry Oberlin College 1994 - 1999
Bachelor of Music, Bachelors, Bachelor of Arts, Biochemistry, Chemistry Indiana University–Purdue University Indianapolis
Master of Science, Masters Carroll High School
Skills:
Tuba
Drug Discovery
Medicinal Chemistry
Hplc
Lc Ms
Drug Development
Organic Chemistry
Chromatography
Technology Transfer
Glp
Clinical Development
Pharmaceutical Industry
Analytical Chemistry
Biotechnology
Cro

Publications

Us Patents

3-Indazolyl-4-Pyridylisothiazoles

View page
US Patent:
20090253750, Oct 8, 2009
Filed:
Mar 18, 2009
Appl. No.:
12/406139
Inventors:
Thomas Charles Britton - Carmel IN, US
Veronique Dehlinger - Surrey, GB
Adam Michael Fivush - Fishers IN, US
Sean Patrick Hollinshead - Indianapolis IN, US
Benjamin Paul Vokits - New York NY, US
International Classification:
A61K 31/4439
C07D 417/04
A61P 25/22
US Classification:
514338, 5462711
Abstract:
The present invention provides 3-indazoyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and methods of using the same, as well as processes for preparing the same, and intermediates thereof.

Triazolopyridine Inhibitors Of Myeloperoxidase

View page
US Patent:
20200291015, Sep 17, 2020
Filed:
Mar 10, 2017
Appl. No.:
16/083951
Inventors:
- Princeton NJ, US
Carol Hui HU - New Hope PA, US
Meriah Neissel Valente - Bedminster NJ, US
Scott A. Shaw - Lawrence Township NJ, US
Benjamin P. Vokits - New York City NY, US
Oz Scott Halpern - Robbinsville NJ, US
International Classification:
C07D 471/04
Abstract:
The present invention provides compounds of Formula (I). wherein A and Z are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and may be useful for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.

Triazolopyridine And Triazolopyrimidine Inhibitors Of Myeloperoxidase

View page
US Patent:
20170247396, Aug 31, 2017
Filed:
Sep 9, 2015
Appl. No.:
15/510168
Inventors:
- Princeton NJ, US
Andrew Quoc Viet - Schwenksville PA, US
Scott A. Shaw - Lawrence Township NJ, US
Benjamin P. Vokits - New York City NY, US
Ellen K. Kick - Ewing NJ, US
Meriah Neissel Valente - Bedminister NJ, US
Andrew K. Dilger - Ewing NJ, US
Kumar Balashanmuga Pabbisetty - Piscataway NJ, US
Sutjano Jusuf - Ardmore PA, US
International Classification:
C07D 519/00
C07D 487/04
C07D 471/04
Abstract:
The present invention provides compounds of Formula (I): wherein A and Rare each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
Control profile
Benjamin P Vokits from New York, NY, age ~49 Get Report